NCT00004776View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 1993

Conditions
Lennox-Gastaut Syndrome
Interventions
DRUG

topiramate

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

National Center for Research Resources (NCRR)

NIH